Cargando…
A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) represents a major public health concern, with an ongoing need for new effective treatments. Bedaquiline is an oral diarylquinoline that has shown encouraging treatment success and culture conversion rates in MDR-TB. METHODS: A South Korean patie...
Autores principales: | Shim, Tae Sun, Pai, Helen, Mok, JeongHa, Lee, Seung Heon, Kwon, Yong-Soo, Choi, Jae Chol, Park, JaeSeok, Birmingham, Eileen, Mao, Gary, Alquier, Lori, Davis, Kourtney, Thoret-Bauchet, Florence, Kim, Ji Hyun, Kim, Hyeongyeong, Bakare, Nyasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828359/ https://www.ncbi.nlm.nih.gov/pubmed/36624432 http://dx.doi.org/10.1186/s12879-022-07955-6 |
Ejemplares similares
-
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
por: Pai, Helen, et al.
Publicado: (2022) -
Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
por: Kang, Yewon, et al.
Publicado: (2022) -
Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021) -
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
por: Mbuagbaw, Lawrence, et al.
Publicado: (2019) -
Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
por: Kambili, C., et al.
Publicado: (2022)